BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 865570)

  • 41. [Serum alkaline phosphatase izoenzymes in childhood during long-term primidone therapy for convulsions].
    Fichsel H; Spiess S
    Klin Padiatr; 1982; 194(5):332-4. PubMed ID: 7144052
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Acute-on-chronic renal failure precipitated by clofibrate.
    Dosa S; Mallick NP; Slotki IN
    Lancet; 1976 Jan; 1(7953):250. PubMed ID: 55557
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V; Cutrupi S; Pizzini P; Mallamaci F; Tripepi G; Zoccali C
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Alkaline phosphatase isoenzymes in experimental rickets in rats].
    Casey H; Capanni P; Zanobini A; Firenzuoli AM
    Boll Soc Ital Biol Sper; 1978 Jul; 54(14):1326-30. PubMed ID: 747685
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experience in using the determination of bone alkaline phosphatase in diseases of the maxillofacial area].
    Kulikova VS; Veretinskaia AG; Kiriukhina SA; Gavrilova NV; Kosorukova NIa
    Vestn Akad Med Nauk SSSR; 1984; (12):63-5. PubMed ID: 6531982
    [No Abstract]   [Full Text] [Related]  

  • 46. [Analysis of isoenzymes and its significance: alkaline phosphatase].
    Iino S; Miki K; Suzuki H
    Rinsho Byori; 1981; (Suppl 43):29-41. PubMed ID: 7277720
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic implications in the elevation of serum activity of intestinal alkaline phosphatase in chronic renal failure.
    Stĕpán J; Havránek T; Jelínková E; Straková M; Skrha J; Pacovský V
    Experientia; 1984 Aug; 40(8):896-8. PubMed ID: 6468612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate.
    Probstfield JL; Statland BE; Gorman L; Hunninghake DB
    Metabolism; 1983 Aug; 32(8):818-21. PubMed ID: 6135138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The dialysis patient with persisting elevation of bone alkaline phosphatase after parathyroidectomy.
    Lorho R; Mourad G; Couret I; Argilés A
    Nephrol Dial Transplant; 1998 Sep; 13(9):2394-6. PubMed ID: 9761535
    [No Abstract]   [Full Text] [Related]  

  • 50. Untoward effects of clofibrate in hemodialyzed patients.
    Kijima Y; Sasaoka T; Kanayama M; Kubota S
    N Engl J Med; 1977 Mar; 296(9):515. PubMed ID: 834232
    [No Abstract]   [Full Text] [Related]  

  • 51. [Activity of alkaline phosphatase of leukocytes in patients with renal failure treated with dialysis].
    Kuska J
    Pol Arch Med Wewn; 1970 Jun; 44(6):609-15. PubMed ID: 5449801
    [No Abstract]   [Full Text] [Related]  

  • 52. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 53. Intestinal alkaline phosphatase in patients with chronic renal failure.
    Alpers DH; DeSchryver-Kecskemeti K; Goodwin CL; Tindira CA; Harter H; Slatopolsky E
    Gastroenterology; 1988 Jan; 94(1):62-7. PubMed ID: 3335299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.
    Bridgman JF; Rosen SM; Thorp JM
    Lancet; 1972 Sep; 2(7776):506-9. PubMed ID: 4115569
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical-radiographic studies of the oral cavity in patients on maintenance hemodialysis].
    Papademetriou D; Memmos D; Liamos O; Papademetriou M; Hatzifotiadis D
    Stomatologia (Athenai); 1985; 42(1):63-72. PubMed ID: 3870235
    [No Abstract]   [Full Text] [Related]  

  • 56. Blood and urinary cadmium in chronic renal failure.
    Willden EG; Hyne BE
    Nephron; 1974; 13(3):253-7. PubMed ID: 4418784
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on bone disease and serum A1-P isozymes of patient on long term regular hemodialisis (author's transl)].
    Maruyama Y; Suemori R; Aoyama H; Hijioka T; Shiomi T; Ijuin M; Motomiya Y; Hiramatsu T; Okajima E; Komada S; Kondo TU
    Nihon Jinzo Gakkai Shi; 1982 Jan; 24(1):63-70. PubMed ID: 7098136
    [No Abstract]   [Full Text] [Related]  

  • 58. Myokymia, unusual side-effect of clofibrate.
    Teräväinen H; Mäkitie J
    Lancet; 1976 Dec; 2(7998):1298. PubMed ID: 63766
    [No Abstract]   [Full Text] [Related]  

  • 59. Clofibrate and the liver.
    Schwandt P; Klinge O; Immich H
    Lancet; 1978 Aug; 2(8084):325. PubMed ID: 79123
    [No Abstract]   [Full Text] [Related]  

  • 60. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients.
    De Broe ME; Van Hoof VO
    Clin Chem; 1991 Jun; 37(6):783-4. PubMed ID: 2049842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.